메뉴 건너뛰기




Volumn 15, Issue 1, 2015, Pages

Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods

Author keywords

Anidulafungin; Antifungal; Candida spp.; Caspofungin; CLSI; EUCAST; Micafungin

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; MICAFUNGIN; ANTIFUNGAL AGENT; ECHINOCANDIN; LIPOPEPTIDE;

EID: 84929615817     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-015-0442-4     Document Type: Article
Times cited : (26)

References (31)
  • 1
    • 79955625171 scopus 로고    scopus 로고
    • Current perspectives on echinocandin class drugs
    • 3913534 1:CAS:528:DC%2BC3MXltlegs7w%3D 21526945
    • Perlin DS. Current perspectives on echinocandin class drugs. Future Microbiol. 2011;6:441-57.
    • (2011) Future Microbiol , vol.6 , pp. 441-457
    • Perlin, D.S.1
  • 2
    • 79955538785 scopus 로고    scopus 로고
    • Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
    • 1:CAS:528:DC%2BC3MXntlGktL8%3D 21353623
    • Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat. 2011;14:164-76.
    • (2011) Drug Resist Updat , vol.14 , pp. 164-176
    • Pfaller, M.A.1    Diekema, D.J.2    Andes, D.3    Arendrup, M.C.4    Brown, S.D.5    Lockhart, S.R.6
  • 3
    • 84857176658 scopus 로고    scopus 로고
    • Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata
    • 3294882 1:CAS:528:DC%2BC38XjsVKls70%3D 22203604
    • Spreghini E, Orlando F, Sanguinetti M, Posteraro B, Giannini D, Manso E, et al. Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata. Antimicrob Agents Chemother. 2012;56:1215-22.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 1215-1222
    • Spreghini, E.1    Orlando, F.2    Sanguinetti, M.3    Posteraro, B.4    Giannini, D.5    Manso, E.6
  • 4
    • 84865378162 scopus 로고    scopus 로고
    • In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis
    • 1:CAS:528:DC%2BC38Xht1egt7rI 22635526
    • Spreghini E, Orlando F, Tavanti A, Senesi S, Giannini D, Manso E, et al. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis. J Antimicrob Chemother. 2012;67:2195-202.
    • (2012) J Antimicrob Chemother , vol.67 , pp. 2195-2202
    • Spreghini, E.1    Orlando, F.2    Tavanti, A.3    Senesi, S.4    Giannini, D.5    Manso, E.6
  • 5
    • 84921938023 scopus 로고    scopus 로고
    • Echinocandin resistance, susceptibility testing and prophylaxis: Implications for patient management
    • 1:CAS:528:DC%2BC2cXhs1ymtL3L 25255923
    • Perlin DS. Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management. Drugs. 2014;74:1573-85.
    • (2014) Drugs , vol.74 , pp. 1573-1585
    • Perlin, D.S.1
  • 6
    • 60549098868 scopus 로고    scopus 로고
    • Clinical practice guidelines for the managementof candidiasis: 2009 Update by the Infectious Diseases Society of America
    • 1:CAS:528:DC%2BD1MXjslantLY%3D 19191635
    • Pappas PG, Kauffman CA, Andes D, Benjamin Jr DK, Calandra TF, Edwards Jr JE, et al. Clinical practice guidelines for the managementof candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-35.
    • (2009) Clin Infect Dis , vol.48 , pp. 503-535
    • Pappas, P.G.1    Kauffman, C.A.2    Andes, D.3    Benjamin, D.K.4    Calandra, T.F.5    Edwards, J.E.6
  • 7
    • 84867716124 scopus 로고    scopus 로고
    • ESCMID∗ guideline for the diagnosis and management of Candida diseases 2012: Adults with haematological malignancies and after haematopoietic stemcell transplantation (HCT)
    • 1:STN:280:DC%2BC3s3mtVansQ%3D%3D 23137137
    • Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, et al. ESCMID∗ guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stemcell transplantation (HCT). Clin Microbiol Infect. 2012;18 Suppl 7:53-67.
    • (2012) Clin Microbiol Infect , vol.18 , pp. 53-67
    • Ullmann, A.J.1    Akova, M.2    Herbrecht, R.3    Viscoli, C.4    Arendrup, M.C.5    Arikan-Akdagli, S.6
  • 8
    • 84888021773 scopus 로고    scopus 로고
    • Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: Critical appraisal
    • 1:STN:280:DC%2BC2c%2Fkt1yluw%3D%3D 24118188
    • Leroux S, Ullmann AJ. Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal. Clin Microbiol Infect. 2013;19:1115-21.
    • (2013) Clin Microbiol Infect , vol.19 , pp. 1115-1121
    • Leroux, S.1    Ullmann, A.J.2
  • 11
    • 40549124325 scopus 로고    scopus 로고
    • EUCAST definitive document EDef 7.1: Method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
    • Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect. 2008;14:398-405.
    • (2008) Clin Microbiol Infect , vol.14 , pp. 398-405
  • 12
    • 84862606187 scopus 로고    scopus 로고
    • EUCAST technical note on the EUCAST definitive document EDef 7.2: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)
    • 1:CAS:528:DC%2BC38XhtFOhtrjI 22563750
    • Arendrup MC, Cuenca-Estrella M, Lass-Florl C, Hope WW. EUCAST-AFST. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin Microbiol Infect. 2012;18:E246-7.
    • (2012) Clin Microbiol Infect , vol.18 , pp. E246-E247
    • Arendrup, M.C.1    Cuenca-Estrella, M.2    Lass-Florl, C.3    Hope, W.W.4
  • 13
    • 84900467753 scopus 로고    scopus 로고
    • EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole
    • 24417759
    • Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW, European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole. Mycoses. 2014;57:377-9.
    • (2014) Mycoses , vol.57 , pp. 377-379
    • Arendrup, M.C.1    Cuenca-Estrella, M.2    Lass-Flörl, C.3    Hope, W.W.4
  • 14
    • 84878833362 scopus 로고    scopus 로고
    • A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade
    • 1:STN:280:DC%2BC3srisVynug%3D%3D 23559357
    • Tortorano AM, Prigitano A, Lazzarini C, Passera M, Deiana ML, Cavinato S, et al. A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade. Infection. 2013;41:655-62.
    • (2013) Infection , vol.41 , pp. 655-662
    • Tortorano, A.M.1    Prigitano, A.2    Lazzarini, C.3    Passera, M.4    Deiana, M.L.5    Cavinato, S.6
  • 15
    • 84864742371 scopus 로고    scopus 로고
    • Echinocandin resistance in Candida species: Mechanisms of reduced susceptibility and therapeutic approaches
    • 22811350
    • Beyda ND, Lewis RE, Garey KW. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012;46:1086-96.
    • (2012) Ann Pharmacother , vol.46 , pp. 1086-1096
    • Beyda, N.D.1    Lewis, R.E.2    Garey, K.W.3
  • 16
    • 84911980763 scopus 로고    scopus 로고
    • Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey
    • 1:CAS:528:DC%2BC2cXhtFCqtrbE 25012821
    • Faria-Ramos I, Neves-Maia J, Ricardo E, Santos-Antunes J, Silva AT, Costa-de-Oliveira S, et al. Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey. Eur J Clin Microbiol Infect Dis. 2014;33:2241-7.
    • (2014) Eur J Clin Microbiol Infect Dis , vol.33 , pp. 2241-2247
    • Faria-Ramos, I.1    Neves-Maia, J.2    Ricardo, E.3    Santos-Antunes, J.4    Silva, A.T.5    Costa-De-Oliveira, S.6
  • 17
    • 84896870399 scopus 로고    scopus 로고
    • Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011
    • 3957835 24366741
    • Guinea J, Zaragoza O, Escribano P, Martín-Mazuelos E, Pemán J, Sánchez-Reus F, et al. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother. 2014;58:1529-37.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 1529-1537
    • Guinea, J.1    Zaragoza, O.2    Escribano, P.3    Martín-Mazuelos, E.4    Pemán, J.5    Sánchez-Reus, F.6
  • 19
  • 20
    • 84887463139 scopus 로고    scopus 로고
    • Interlabo-ratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: Should the clinical laboratory be testing this agent?
    • 3837874 1:STN:280:DC%2BC3sbmsV2qsw%3D%3D 24018263
    • Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, et al. Interlabo-ratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother. 2013;57:5836-42.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 5836-5842
    • Espinel-Ingroff, A.1    Arendrup, M.C.2    Pfaller, M.A.3    Bonfietti, L.X.4    Bustamante, B.5    Canton, E.6
  • 21
    • 84927788542 scopus 로고    scopus 로고
    • Echinocandin resistance: An emerging clinical problem?
    • 1:CAS:528:DC%2BC2cXhvVKrsL3J 25304391
    • Arendrup MC, Perlin DS. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis. 2014;27:484-92.
    • (2014) Curr Opin Infect Dis , vol.27 , pp. 484-492
    • Arendrup, M.C.1    Perlin, D.S.2
  • 22
    • 46249106060 scopus 로고    scopus 로고
    • A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility
    • 2443908 1:CAS:528:DC%2BD1cXot1Oitrg%3D 18443110
    • Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother. 2008;52:2305-12.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2305-2312
    • Garcia-Effron, G.1    Katiyar, S.K.2    Park, S.3    Edlind, T.D.4    Perlin, D.S.5
  • 23
    • 84863337736 scopus 로고    scopus 로고
    • Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata: Results from the SENTRY Antimicrobial Surveillance Program (2006-2010) and the Centers for Disease Control and Prevention Population-Based Surveillance (2008-2010)
    • 3318516 1:CAS:528:DC%2BC38Xmt1yktbw%3D 22278842
    • Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata: results from the SENTRY Antimicrobial Surveillance Program (2006-2010) and the Centers for Disease Control and Prevention Population-Based Surveillance (2008-2010). J Clin Microbiol. 2012;50:1199-203.
    • (2012) J Clin Microbiol , vol.50 , pp. 1199-1203
    • Pfaller, M.A.1    Castanheira, M.2    Lockhart, S.R.3    Ahlquist, A.M.4    Messer, S.A.5    Jones, R.N.6
  • 24
    • 84878342622 scopus 로고    scopus 로고
    • Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations
    • 3658363 23487382
    • Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56:1724-32.
    • (2013) Clin Infect Dis , vol.56 , pp. 1724-1732
    • Alexander, B.D.1    Johnson, M.D.2    Pfeiffer, C.D.3    Jiménez-Ortigosa, C.4    Catania, J.5    Booker, R.6
  • 25
    • 54049093652 scopus 로고    scopus 로고
    • Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection
    • 2565919 1:CAS:528:DC%2BD1cXht1Srur7N 18676885
    • Thompson GR, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS, Patterson TF. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Chemother. 2008;52:3783-5.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 3783-3785
    • Thompson, G.R.1    Wiederhold, N.P.2    Vallor, A.C.3    Villareal, N.C.4    Lewis, J.S.5    Patterson, T.F.6
  • 27
    • 44449153708 scopus 로고    scopus 로고
    • Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment
    • 2415792 1:CAS:528:DC%2BD1cXmvVaitbo%3D 18378714
    • Cleary JD, Garcia-Effron G, Chapman SW, Perlin DS. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob Agents Chemother. 2008;52:2263-5.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2263-2265
    • Cleary, J.D.1    Garcia-Effron, G.2    Chapman, S.W.3    Perlin, D.S.4
  • 28
    • 0035123002 scopus 로고    scopus 로고
    • Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp.
    • 87770 1:CAS:528:DC%2BD3MXhtlGrtb8%3D 11158101
    • Cuenca-Estrella M, Díaz-Guerra TM, Mellado E, Rodríguez-Tudela JL. Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp. J Clin Microbiol. 2001;39:525-32.
    • (2001) J Clin Microbiol , vol.39 , pp. 525-532
    • Cuenca-Estrella, M.1    Díaz-Guerra, T.M.2    Mellado, E.3    Rodríguez-Tudela, J.L.4
  • 29
    • 77951786826 scopus 로고    scopus 로고
    • Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species
    • 2863935 1:CAS:528:DC%2BC3cXnt1Cgur8%3D 20335424
    • Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. J Clin Microbiol. 2010;48:1592-9.
    • (2010) J Clin Microbiol , vol.48 , pp. 1592-1599
    • Pfaller, M.A.1    Castanheira, M.2    Diekema, D.J.3    Messer, S.A.4    Moet, G.J.5    Jones, R.N.6
  • 30
    • 84900492654 scopus 로고    scopus 로고
    • Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
    • 1:CAS:528:DC%2BC2cXmtlCit7s%3D 24736096
    • Pfaller MA, Castanheira M, Messer SA, Rhomberg PR, Jones RN. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. Diagn Microbiol Infect Dis. 2014;79:198-204.
    • (2014) Diagn Microbiol Infect Dis , vol.79 , pp. 198-204
    • Pfaller, M.A.1    Castanheira, M.2    Messer, S.A.3    Rhomberg, P.R.4    Jones, R.N.5
  • 31
    • 84900829814 scopus 로고    scopus 로고
    • Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
    • 24618110
    • Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW. Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp. Drug Resist Updat. 2013;16:81-95.
    • (2013) Drug Resist Updat , vol.16 , pp. 81-95
    • Arendrup, M.C.1    Cuenca-Estrella, M.2    Lass-Flörl, C.3    Hope, W.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.